首页> 美国卫生研究院文献>other >The Impact of Agent Orange Exposure on Presentation and Prognosis of Patients with Chronic Lymphocytic Leukemia (CLL)
【2h】

The Impact of Agent Orange Exposure on Presentation and Prognosis of Patients with Chronic Lymphocytic Leukemia (CLL)

机译:橙剂暴露对慢性淋巴细胞白血病(CLL)患者的表现和预后的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Exposure to Agent Orange (AO) and the contaminating chemical 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) has been associated with the development of chronic lymphocytic leukemia (CLL). Of the195 veterans diagnosed with CLL from 2001–2010 in a retrospective cohort from the Minneapolis VA, 33 (17%) were exposed to AO. Prognostic factors including Rai stage, lymphocyte doubling time and cytogenetics did not differ between exposed and unexposed patients. Exposed patients were younger at diagnosis (61 vs 72 years, p=0.001) and time to CLL treatment was shorter (9.6 vs 30.2 months, p=0.02). Overall survival did not differ between exposed and unexposed patients on Kaplan Meier analysis, but when adjusted for age, AO exposure had a hazard ratio of death of 1.8 compared to non-exposure (95% CI 0.7–4.5 p=0.24). The high estimate of the mortality hazard combined with the relatively low numbers in the exposure group suggests that further examination in a larger patient population is warranted.
机译:暴露于橙色剂(AO)和污染性化学物质2,3,7,8-四氯二苯并二恶英(TCDD)与慢性淋巴细胞性白血病(CLL)的发展有关。在来自明尼阿波利斯弗吉尼亚州的一项回顾性研究中,从2001年至2010年的195位被诊断为CLL的退伍军人中,有33位(17%)接触过AO。暴露和未暴露患者的预后因素包括Rai分期,淋巴细胞倍增时间和细胞遗传学。暴露的患者在诊断时更年轻(61岁对72岁,p = 0.001),接受CLL治疗的时间更短(9.6对30.2个月,p = 0.02)。在Kaplan Meier分析中,暴露和未暴露患者的总体生存率没有差异,但是根据年龄进行调整后,与未暴露相比,AO暴露的死亡危险比为1.8(95%CI 0.7-4.5 p = 0.24)。较高的死亡率危险估计值与暴露人群中相对较低的数字相结合,表明有必要在更大的患者人群中进行进一步检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号